Effect of Atorvastatin on blood and gasometrical parameters in patients with COPD: a double-blind controlled clinical trial
JBUMS-Journal of Birjand University of Medical Sciences. 2017; 24 (Supp.): 334-341
en Inglés
| IMEMR
| ID: emr-189810
ABSTRACT
Chronic obstructive pulmonary disease [COPD] is a syndrome with progressive and irreversible airflow limitation. The aim of this study was to evaluate the effect of Atorvastatins on blood parameters including blood gasses in patients with COPD. This randomized double-blind, controlled clinical trial study was conducted on the case and control groups of patients with COPD in Vali-e-asr hospital in Birjand in 2015
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Método Doble Ciego
/
Enfermedad Pulmonar Obstructiva Crónica
/
Atorvastatina
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Adulto
/
Anciano
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
J. Birjand Univ. Med. Sci.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS